Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 34, Issue 12, pp 1659–1666 | Cite as

The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure

  • Tarek M. K. Motawi
  • Sherine M. Rizk
  • Nadine W. Maurice
  • Ahmed Mohamed Maged
  • Ayman N. Raslan
  • Ahmed H. Sawaf
Genetics

Abstract

Objective

The aim of this study is to assess the role of AMH in prediction of poor ovarian response as well as the relation between ESR 2 (+ 1730G>A) (rs4986938) and FSHR p.Thr307Ala (c.919A>G, rs6165) SNPs and the poor ovarian response in Egyptian women undergoing IVF procedure. Discovering the genetic variants associated with ovarian response is an important step towards individualized pharmacogenetic protocols of ovarian stimulation.

Methods

We performed a prospective study on 216 young women with unexplained infertility. Ovarian stimulation was performed according to the GnRH antagonist protocol with a fixed daily morning dose of human menopausal gonadotrophin (HMG). The estrogen receptor (ESR2) (+ 1730G>A) (rs4986938) and FSH receptor p.Thr307Ala (c.919A>G, rs6165) single nucleotide polymorphisms (SNPs) were detected by real-time polymerase chain reaction. Serum FSH, Estradiol (E2) and anti-Müllerian hormone (AMH) levels were measured by enzyme-linked immunosorbent assay (ELISA).

Results

This study revealed that the low AMH level was highly significantly related to the poor ovarian response (p < 0.001). Furthermore, the frequency of the ESR2 (AA) genotype and the FSHR (Ala307Ala) genotypes were highly significantly associated with the poor ovarian response (p < 0.001).

Conclusion

The AMH level in combination with the ESR2 and the FSHR gene polymorphisms predict the poor ovarian response to COH in Egyptian women.

Trial registration

ClinicalTrials.gov Identifier: NCT02640976.

Keywords

Assisted reproductive technology In-vitro fertilization Controlled ovarian hyperstimulation Follicle-stimulating hormone receptor Estrogen receptors Single nucleotide polymorphisms Anti-Müllerian hormone Infertility 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

There were not any funding sources.

References

  1. 1.
    Lledo B, Ortiz JA, Llacer J, Bernabeu R. Pharmacogenetics of ovarian response. Pharmacogenomics. 2014;15:885–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Gearhart J, Coutifaris C. In vitro fertilization, the Nobel Prize, and human embryonic stem cells. Cell Stem Cell. 2011;8:12–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170–207.CrossRefPubMedGoogle Scholar
  4. 4.
    Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, et al. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in Vitro fertilization programs with ICSI. PLoS One. 2012;7:1–16.CrossRefGoogle Scholar
  5. 5.
    Ubaldi F, Vaiarelli A, D’Anna R, Rienza L. Management of Poor Responders in IVF: is there anything new? Bio Med Research International. 2014;2014:1–10.CrossRefGoogle Scholar
  6. 6.
    Keane K, Cruzat VF, Wagle S, Chaudhary N, Newsholme P, Yovich J. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome. Reprod Biol. 2017;17(1):51–9. doi: 10.1016/j.repbio.2016.12.002.CrossRefPubMedGoogle Scholar
  7. 7.
    Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701. doi: 10.1093/humupd/dmu020.CrossRefPubMedGoogle Scholar
  8. 8.
    Lledo B, Guerrero J, Turienzo A, Ortiz JA, Morales R, Ten J, et al. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics. 2013;23:262–8.CrossRefPubMedGoogle Scholar
  9. 9.
    De Mattos CS, Trevisan CM, Peluso C, Adami F, Cordts EB, Christofolini DM, et al. ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women. Journal of Ovarian Research. 2014;7:1–9.CrossRefGoogle Scholar
  10. 10.
    Altmäe S, Hovatta O, Stravreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011;17(6):813–28.CrossRefPubMedGoogle Scholar
  11. 11.
    Ochsenkühn R, von Schönfeldt SM. FSH receptor polymorphisms and ovarian function. Med Reprod Gynecol Endocrinol. 2009;11:265–70.Google Scholar
  12. 12.
    Rod A, Jarzabek K, Wolczynski S, Benhaim A, Reznik Y, Denoual-Ziad C, et al. ESR1 and FSHR gene polymorphisms influence ovarian response to FSH in poor responder women with normal FSH levels. Endocrinol Metab Synd. 2014;3:1–5.Google Scholar
  13. 13.
    Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility. Reprod Biol Endocrinol. 2010;8:64.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Broer SL, D’olleman M, Disseldorp JV, Broeze KA, Opmeer BC, PMM B, et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. FertilSteril. 2013;100:420–9.Google Scholar
  15. 15.
    Vaze-Parab A, Bhatt P, Parihar LM, Baldawa P. Anti-mullerian hormone, follicular phase follicle stimulating hormone and antral follicular count as predictors of ovarian response in assisted reproductive technique cycles. IVF Lite. 2014;1:32–5.CrossRefGoogle Scholar
  16. 16.
    Laan M, Grigorova M, Huhtaniemi IT. Pharamacogenetics of FSH action. Curr Opin Endocrinol Diabetes Obes. 2012;19:220–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Tarek M. K. Motawi
    • 1
  • Sherine M. Rizk
    • 1
  • Nadine W. Maurice
    • 1
  • Ahmed Mohamed Maged
    • 2
    • 3
  • Ayman N. Raslan
    • 2
  • Ahmed H. Sawaf
    • 2
  1. 1.Department of Biochemistry, Faculty of PharmacyCairo UniversityGizaEgypt
  2. 2.Obstetrics and Gynaecology DepartmentCairo UniversityGizaEgypt
  3. 3.GizaEgypt

Personalised recommendations